Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...

Indeed, the next era of blockbuster cancer therapeutics could be focused on treating what ends up being the cause of death for up to 40% of cancer patients – cachexia. Historically, cachexia has ...

Registered dietitian Suzanne Fisher offers explains why nutrition is important to support metastatic breast cancer. She ...

Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates ...

Reports Q3 revenue $234,000, consensus $179.25k. “We had a very productive quarter, with both PALISADE-3 and PALISADE-4 advancing towards ...

Kexing Biopharm Co., Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05, Human Interferon α1b Inhalation Solution, a self-developed product by ...

A new effort is underway to legalize not just medical marijuana but recreational use, too. But is that the best route forward ...

The high prevalence of sarcopenia in patients with ovarian and endometrial cancers underscores the importance of early ...

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.

Recent studies show how dietary choices may affect a person's risk of cancer, particularly colorectal cancer, and cancer of ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

AI is already being used in clinics to help analyze imaging data, such as X-rays and scans. But the recent arrival of ...